Find a Biotech job in Boston

Wyeth, Progenics get European constipation drug OK

Drug developers Wyeth and Progenics Pharmaceuticals Inc. said Thursday European regulators approved Relistor as a treatment for constipation related to pain drugs taken by terminally ill patients. (AP, 1:30 p.m.)

Opening Glance: Biotech shares open mixed

Shares of biotechnology companies opened mixed Thursday as the broader market rose after the Labor Department reported that the nation's unemployment rate held steady at 5.5 percent last month, easing concerns over a worsening job losses. (AP, 9:46 a.m.)

FDA lifts clinical hold on Adolor bowel drug

Adolor Corp. said Thursday the Food and Drug Administration has lifted its clinical hold on the company's Entereg drug in chronically constipated patients taking opioid pain drugs. (AP, 8:39 a.m.)

Transition Therapeutics CFO adds president role

Biopharmaceutical company Transition Therapeutics Inc. said Thursday it named Chief Financial Officer Elie Farah to the additional role of president. (AP, 8:24 a.m.)

Lawsuit targets Riceland in modified rice claim

A lawsuit filed Wednesday claims that Riceland Foods Inc. was involved in development of a genetically modified rice strain and delayed for months telling farmers that the rice had gotten into the food supply, news that led a number of nations to stop buying American rice. (AP, 7/2/08)